These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 6351023

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prediction by a modified mixed leukocyte reaction assay of graft-versus-host disease and graft rejection after allogeneic bone marrow transplantation.
    Bishara A, Brautbar C, Nagler A, Slavin S, Leshem B, Cohen I, Kedar E.
    Transplantation; 1994 May 27; 57(10):1474-9. PubMed ID: 8197610
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Severe eosinophilia as a manifestation of acute graft-versus-host disease.
    Paralkar VR, Goradia A, Luger SM, Loren AW.
    Oncology; 2008 May 27; 75(3-4):134-6. PubMed ID: 18791329
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y, Guo K, Chen Y, Song Z, Li J, Deng L.
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug 27; 23(8):411-4. PubMed ID: 12411044
    [Abstract] [Full Text] [Related]

  • 10. Emerging drugs for acute graft-versus-host disease.
    Khaled Y, Reddy P, Krijanovski O.
    Expert Opin Emerg Drugs; 2009 Jun 27; 14(2):219-32. PubMed ID: 19519285
    [Abstract] [Full Text] [Related]

  • 11. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
    Michallet M, Perrin MC, Belhabri A, Molina L, Nicolini F, Tigaud JD, Sotto JJ, Guyotat D, Fière D, Archimbaud E.
    Bone Marrow Transplant; 1999 Jan 27; 23(2):145-50. PubMed ID: 10197799
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Atypical acute graft-versus-host disease.
    Shin J, Hong W, Song H, Choi G, Kim YC.
    Am J Dermatopathol; 2007 Dec 27; 29(6):576-7. PubMed ID: 18032957
    [Abstract] [Full Text] [Related]

  • 16. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
    Schwinghammer TL, Bloom EJ.
    Clin Pharm; 1993 Oct 27; 12(10):736-61. PubMed ID: 8258255
    [Abstract] [Full Text] [Related]

  • 17. Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation.
    Saad AG, Alyea EP, Wen PY, Degirolami U, Kesari S.
    J Clin Oncol; 2009 Oct 20; 27(30):e147-9. PubMed ID: 19667266
    [No Abstract] [Full Text] [Related]

  • 18. [The graft-vs-host reaction in military transfusion treatment].
    Shevchenko IuL, Danil'chenko VV, Zhiburt EB, Serebrianaia NB, Katkova IV, Khubulava GG.
    Voen Med Zh; 1997 Feb 20; 318(2):32-5. PubMed ID: 9148576
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.